Gabriel, Baby Boy 1 .
HRN: 23-24-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/01/2023
07/07/2023
IVT
29mg
OD
Prematurity
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes